Background: Only one in ten patients survives cardiac arrest (CA), underscoring the need to 24 improve CA management. Isoflurane has shown cardio-and neuroprotective effects in animal 25 models of ischemia/reperfusion injury. Therefore, beneficial effect of isoflurane should be 26 tested in an experimental CA model. We hypothesize that isoflurane anesthesia improves 27 short-term outcome following resuscitation from CA compared with a subcutaneous 28 fentanyl/fluanisone/midazolam anesthesia. 
Introduction 55
Although survival after cardiac arrest (CA) has improved over the past decades, overall 56 mortality remains unacceptable high at 90%(34). In view of this dismal prognosis, it is crucial 57 to examine whether certain resuscitation strategies have the potential to improve outcome. To 58 this end, the pre-and postconditioning effects of volatile anesthetics are well known, and 59 experimental research has shown improved cardiac function and diminished neurological 60 injury following ischemia/reperfusion injury and CA (5, 14, 26, 27) . 61
The study of protective resuscitation strategies after CA invariably involves the use of 62 anesthetized animals, and the choice of anesthetics in animal models may interfere with 63 factors of importance to subsequent recovery, both prior to the induction of CA, and during 64 resuscitation(19). High coronary perfusion pressure (CPP) and cerebral blood flow (CBF) are 65 known predictors of ROSC, and volatile anesthetics may, by their effect on these parameters, 66 therefore increase the rate of ROSC (16, 23, 25) . Endothelin-1 is a known predictor of 67 resuscitation failure and a lack of response to epinephrine during CPR(30, 31), and the 68 Endothelin-1 induced vasoconstriction is affected by volatile anesthetics (1) . Finally, oxygen 69 debt is a good predictor of outcome in animal models of shock(28). Oxygen debt is 70
proportional to the duration of CA and to the systemic O 2 consumption (VO 2 ) before CA. 71
Anesthetics affect VO 2 and the choice of anesthesia could therefore affect the ROSC rate(8, 72 24, 33). 73
Objective 74
The aims of the current study was to: 1) explore the potential beneficial effect on ROSC rate 75 of isoflurane anesthesia when compared to fentanyl/fluanisone/midazolam (FFM) anesthesia 76 in an experimental model of cardiac arrest and 2) to investigate the impact of anesthesia on 77 important outcome measures in experimental CA research. 78 79
Hypothesis 80
The primary hypothesis was that anesthesia with isoflurane improves the rate of ROSC when 81 compared to anesthesia with FFM. The secondary hypotheses were that the potential effect 82 on ROSC rate is attributable to changes in CPP, CBF, or VO 2 and that isoflurane anesthesia 83 increases plasma levels of Endothelin-1 and catecholamines. 
Study design 93
A list randomizing the animals to either isoflurane or FFM anesthesia was prepared before 94 starting the study (See Figure 1) . It was not possible to blind the primary investigator during 95 the experimental procedures, but all subsequent data analyses were carried out blinded. 
Experimental animals and housing 103
Male Sprague Dawley rats (Taconic, Denmark) weighing 400g were used for this study. Rats 104 were housed pairwise at room temperature and humidity (22-23°C, 45%), at 12-hour 105 light/dark cycle, with free access to food and water. Cages were enriched with bedding 106 material, tube for hiding, and toys. 107 108
Experimental procedures 109

Animal preparation 110
To make groups comparable the animals where anesthetized accordingly: 111 Induction: Anesthesia in the two groups was induced by either 5% isoflurane or subcutaneous 112 (sc) injection of FFM (fentanyl 0.0788 mg/ml, fluanisone 2.5 mg/ml and midazolam 1.25 113 mg/ml) (2.4ml/kg). In the FFM group a single dose of Ketamine (100mg/kg) was administered 114 intraperitoneally (ip) to prevent pharyngeal reflexes during intubation. 115
Surgery: During surgical preparation anesthesia was maintained with 2.5% isoflurane while 116 anesthesia in the FFM group was maintained with sc injection of a lower FFM dose (0.6ml/kg) 117 every 30 min 118
Cardiac arrest: During cardiac arrest neither isoflurane nor FFM was administered. 119
Resuscitation: During resuscitation isoflurane was resumed at 1% in the isoflurane group, 120 where as FFM administration was postponed to match the lower level of isoflurane. 121 Post-ROSC: Following ROSC, as no painful procedures were carried out, anesthesia was 122 maintained with 1% isoflurane in the isoflurane group and administration of FFM was delayed 123 corresponding to the time from start of asphyxia until ROSC resulting in an accordingly lower 124 dose in the FFM group (32) . 125
The level of anesthesia was monitored by, tail pinch, whisker stimulation, and changes in 126 blood pressure and pulse throughout the study. 127
Before tracheotomy, animals were orally intubated using a 17-gauge venous catheter and 128 ventilated with 30% O 2 and a tidal volume of 8ml/kg. For the VO 2 measurements, a 129 tracheotomy was performed to prevent loss of expiratory gasses. After tracheotomy, tidal 130 volume was reduced to 5ml/kg. The ventilation rate was adjusted to maintain PaCO 2 at 31-131 44mmHg. The temperature was kept at 36.5-37.5°C by a feedback-controlled heating pad. 132
Saline, 2ml/kg/h, was administered during preparation. The left femoral artery was 133 catheterized for invasive blood pressure measurement and arterial sampling, using a PE90 134 tube connected to a 22-gauge venous catheter. The femoral vein was catheterized using a 135 2.4.3 Systemic O 2 consumption (VO 2 ) and CO 2 production (VCO 2 ) 160 VO 2 and VCO 2 in steady state conditions were determined by respirometry by measuring 161 oxygen and carbon dioxide concentrations in the inspiratory and expiratory air, using serially 162 connected O 2 analyzer (Servomex, Crowborough, England), CO 2 sensor P-61B (AEI 163
Technologies, Pittsburg, PA, USA), and CO 2 analyzer P-61B (AEI Technologies, Pittsburg, 164 PA, USA). To collect all expiratory gas, a tube with a volume above the minute volume was 165 connected to the expiratory line via a t-piece; and a pump to provide suction through the 166 system was connected after the gas analyzers. VO 2 and VCO 2 were calculated as the product 167 of the suction flow rate through the analyzers and the integrated area below or above 168 baseline of the expiratory gas curves as a function of time and values were reported as 169 ml(STPD)/min/kg. Data collection and subsequent integration was done using Biopac MP150 170 and AcqKnowledge acquisition software (Biopac systems, Goleta, CA, USA) as previously 171 described (21) . 172
Blood samples 173
Blood samples (1.4ml ≈ 5% of total blood volume(32)) were collected in EDTA-coated tubes 174 at baseline and 30 min after ROSC and centrifuged at 0°C and 1600g for 15 min. Plasma was 175 stored at -80°C until analysis. Endothelin-1 (R&D systems, Minneapolis, MN, USA), and 176 catecholamines (DRG international, Springfield, NJ, USA) were analyzed using an ELISA 177 assay following the manufacturer's recommendation. Detection limits and intraassay variation 178
were: Endothelin-1 (0.29pg/ml, 15%), epinephrine(5pg/ml, 33%), norepinephrine(16pg/ml, 179 5%), dopamine(29pg/ml, 5%). 180 181
Sample size 182
Based on pilot studies, we estimated a ROSC rate of 90% in the isoflurane group and 20% in 183 the FFM group, requiring a sample size of 11 animals per group, with a power of 0.9 and a α 184 of 0.05. 185 186 2.6 Experimental outcomes 187
Primary outcome 188
The primary outcome measure was ROSC defined as a MAP above 40mmHg. 189
Secondary outcomes 190
Secondary outcomes were time to ROSC, CPP and CBF during CPR, systemic oxygen 191 consumption (VO 2 ) and carbon dioxide production (VCO 2 ) at baseline, plasma analysis of 192
Endothelin-1 and catecholamines at baseline and 30 min after ROSC and physiological data. 
Animals included 212
A total of 23 animals (weight 400g ± 14, age 11 weeks) were used for this study. One animal 213 was excluded due to technical error during preparation. The remaining 22 animals were 214 evenly randomized to the two experimental groups, and none were excluded in the 215 subsequent analysis. 216
Baseline data 217
Baseline data are shown in Table 1 . Compared with the FFM group, the isoflurane group had 218 a lower heart rate, a higher temperature, higher CBF, and increased levels of glucose and 219 lactate at baseline. All other baseline parameters were comparable between the two groups, 220 No difference in ROSC rates between the two groups was found (p=0.6) ( 
Physiologic data 236
Physiologic data are shown in Table 1 . The isoflurane group showed a significant increase in 237 MAP, CBF, pH, and hemoglobin during the post-resuscitation period compared with the FFM 238 group. The two animals in the isoflurane group receiving epinephrine in the early post-ROSC 239 phase did not differ from animals not receiving epinephrine in regards to hemodynamic 240 function. In the post-ROSC period, the heart rate increased in the isoflurane group, while the 241 heart rate decreased in the FFM group. The higher lactate in the isoflurane group observed at 242 baseline was also evident immediately after ROSC; however, at 30 min, no difference existed 243 between groups. 244 Figure 2 shows the results of the CPP and CBF measurements after 30 seconds of CPR. The 246 CPP was significantly higher in the isoflurane group than in the FFM group. When comparing 247 CPP based on ROSC vs. no ROSC, CPP was higher in the animals achieving ROSC (Figure  248 2). During CPR, we observed no difference in the CBF between the two groups; however, 249 when categorizing the data based on resuscitation outcome, we did see a higher CBF in the 250 group achieving ROSC. 251 
Coronary perfusion pressure and carotid blood flow 245
255
Systemic O 2 consumption and CO 2 production. 256
Data on VO 2 and VCO 2 are shown in Figure 3 . We observed a trend towards a lower VO 2 in 257 the isoflurane group, however this was not significant (p=0.09). There was no difference in 258 VO 2 when groups were defined according to resuscitation outcome. We observed no 259 difference in VCO 2 , either when groups were defined according to anesthesia received or on 260 the basis of their resuscitation outcome. 
264
FFM=fentanyl/fluanisone/midazolam, ROSC=return of spontaneous circulation.
265
Plasma analyses 266
The results of the plasma analyses are shown in Figure 4 and 5. The isoflurane group 267 showed increased levels of Endothelin-1 at baseline and 30 min after ROSC compared with 268 the FFM group. There was no difference in Endothelin-1 levels when ROSC was compared 269 with no ROSC (Figure 4) . 270
Compared with FFM, isoflurane decreases levels of epinephrine at baseline, however this 271 difference was not found 30 min after ROSC. Norepinephrine and dopamine showed no 272 
Discussion 286
In this rat model of asphyxial CA, we demonstrate how two commonly used anesthetic 287 regimes affect short term outcome measures traditionally used in resuscitation research(12, 288 32). Compared with FFM, isoflurane results in shorter time to ROSC, lower dose of 289 epinephrine, higher CPP during CPR, higher MAP post ROSC, increased plasma levels of 290
Endothelin-1 and decreased levels of epinephrine. Contrary to our hypothesis, this did, 291 however, not translate into an increased ROSC rate. 292
The absence of any difference in ROSC rate between groups despite a higher CPP in the 293 isoflurane group may be attributable to the high CPP in both groups. Despite the difference in 294 CPP among groups, the median CPP in the FFM group was 15.2 mmHg, which leaves a 295 large proportion of the animals in this group above the threshold where ROSC is possible. 296
Had the insult been more severe, animals been older or had comorbidities, the CPP increase 297 caused by isoflurane may have been sufficed to place this group above the critical threshold 298 where ROSC is possible. In our data, the relationship between ROSC and CPP levels ( Figure  299 2B) is in accordance with the literature, where a CPP below 15mmHg is a strong predictor of 300
unsuccessful resuscitation(25). 301
In a porcine model of asphyxial CA, Kurita et al showed a ROSC rate of 100% in the 302 isoflurane group compared to 60% in the propofol/fentanyl group(19). Riess et al recently 303
failed to show increased ROSC rates with the use of volatile anesthesia; however, 304 sevoflurane in this study was compared with no anesthesia(27). In both studies, CPP during 305 CPR was above 15mmHg in all study groups. Likewise, other studies fail to show a benefit on 306 survival or neurological outcome, but report improvement in secondary endpoints such as 307 cardiac function, mitochondrial function, and inflammatory markers(15, 22, 27). The beneficial 308 effect on secondary outcomes is also seen in the present study where MAP and CBF in the 309 post-ROSC phase were higher in the isoflurane group. These benefits may be caused by the 310 increased CPP during CPR, which diminishes the post-resuscitation injury(9). A large 311
proportion of patients resuscitated from cardiac arrest subsequently die in the ICU in part due 312 to neurological and cardiovascular collapse. Improvement in post-ROSC hemodynamic, such 313
as MAP and CBF, may prove important in ameliorating outcome, however a longer follow-up 314 period is needed to investigate this. Previous studies using brief periods of sevoflurane during 315 CPR or after ROSC, demonstrated similar effects on CPP and myocardial function. Hence the 316 effects seen in this study by isoflurane may apply to volatile anesthetics in general (22, 27) . of Endothelin-1 at baseline predicts resuscitation failure and failure to respond 320 hemodynamically to epinephrine(30, 31). These findings could not be reproduced in our 321 study, as baseline Endothelin-1 levels did not differ between animals achieving ROSC and 322 those that did not. Differently, the increased plasma levels of Endothelin-1 in the isoflurane 323 group could explain the higher CPP during resuscitation in the isoflurane group, as the 324 difference in CPP was driven by a higher aortic pressure. This is supported by the results of 325 ROSC period the vasoconstriction caused by Endothelin-1 is believed to increase the 331 afterload causing augmented myocardial dysfunction and worsen cerebrovascular reactivity 332 causing neurological injury (10, 17, 18) . 333
To our knowledge, this study is the first to report on VO 2 in isoflurane-anesthetized rats. We 334 found a metabolism about seven times higher than in humans(3). Comparison of our data 335 with those of other studies of isoflurane anesthesia in other species, shows that our data fit 336
Brody's equation which predicts a curvilinear decrease in mass specific VO 2 with body mass 337 described by a power function(3, 4, 6, 24). Several of these studies show a reduction of VO 2 338 during isoflurane anesthesia comparable to the metabolic depression of sleep(2, 24). 339
However, as we found no significant difference between the groups in our study, isoflurane 340 does not seem to suppress metabolism more than anesthesia in general. These results 341 accordingly show that the beneficial effects of volatile anesthetics reported in other 342 ischemia/reperfusion studies may be caused by other mechanisms than a reduction of the 343 oxygen debt. Additionally, our VO 2 data show that rate of ROSC after CA cannot be predicted 344 from baseline metabolism. 345
Limitations 346
The study was designed to investigate the effect on ROSC rate and therefore a short follow-347 up period of 30 min was chosen. However, after 30 min, the MAP in the FFM group was very 348 low, and a longer follow-up may have revealed a higher mortality in this group. The route of 349 administration was different for the two anesthetics, isoflurane given continuously and FFM 350
given as a bolus every 30 min. When compared to continues isoflurane inhalation, the level of 351 anesthesia varies more with subcutaneous bolus injections, causing a risk of difference in 352 anesthetic level at the time of CA. As both FFM and isoflurane is know to reduce arterial 353 blood pressure, the preparation was timed to ensure that no FFM bolus was given right before 354 asphyxia (mean time from FFM bolus to asphyxia 20min [16;24] ). No bolus was given during 355 asphyxia, CA, or CPR to avoid potential confounding by peak levels of fentanyl/fluanisone or 356 midazolam during resuscitation, and to match the lower isoflurane level during CPR and in the 357 post ROSC period. As anesthesia in the current study was induced prior to cardiac arrest, 358 further studies are warranted to seek a similar protective effect when volatile anesthetics are 359 initiated after the ischemic event. Even though we performed pilot studies and sample size 360 calculations, we cannot entirely ignore the possibility of a type two error in the present study. 361
Another common limitation in ischemia/reperfusion is the size of the insult. If the insult is not 362 severe enough, a potentially protective effect might be missed, which is illustrated by the high 363 ROSC rates in our study. In the present study, rats were subjected to 10 min of CA, which we 364 consider a severe insult. However, the animals were young and healthy, not resembling the 365 average CA patient. Applying the same insult to an aged rat may show different results. Our 366 study did not evaluate neuronal injury, as the focus of our study was hemodynamic 367 parameters and short term outcome. There are conflicting results about the effect of volatile 368 anesthetics on cerebral injury. Several studies on cerebral ischemia/reperfusion injury have 369 demonstrated neuroprotective effects (7, 20, 35) where as exposure of the developing brain to 370 volatile anesthetics may be neurotoxic(13, 29). 371
Implications 372
The quality of CPR is not only important for the ROSC rate, but also for post resuscitation 373 injury. The benefit of volatile anesthetics on CPP, time to ROSC, and adrenalin doses seen in 374 the present and in other studies may prove important in reducing post-resuscitation injury. In 375 the current study, this is illustrated by improved post-ROSC hemodynamics and supported by 376 other studies demonstrating that higher CPP during CPR improves post-resuscitationinjury(9). Furthermore, with the improvement in CPR quality, possibility of prolonged 378 resuscitation attempts with mechanical compression devices, and availability of extracorporal 379 membrane oxygenation, sedation of patients can be necessary during ongoing CPR. In this 380 situation volatile anesthetics could potentially be superior to fentanyl/midazolam anesthesia. 381
As anesthetics are inevitable in resuscitation research, it is crucial to examine their impact on 382 study design and outcome measures. Coronary perfusion pressure, a commonly used 383 outcome measure of CPR quality, cannot be compared among studies using different 384 anesthetic regimes because the CPP is affected by the anesthesia used. When designing 385 new or comparing past studies, we must keep the results of the present study in mind. 386
Conclusion 387
Compared with FFM, isoflurane anesthesia decreases time to ROSC, augments CPP during 388 CPR and MAP after resuscitation, increases plasma levels of Endothelin-1, and decreases 389 catecholamine levels. Even though these changes did not translate into an increased ROSC 390 rate, they are important outcome measures in experimental CA research. 391 392
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